Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Portfolio Companies: RA Capital Management
Wave Life Sciences Ltd. (NASDAQ:WVE)*

Organization & Developments: Wave Life Sciences

Parents

2020: Wave tanks again as Huntington's clinical trial data underwhelm
2021: Wave Life Sciences: Hanging Around $10
2022: Wave Life Sciences (WVE) Investor Presentation - Slideshow_seekingalpha.com
2023: Wave Life Sciences: Huntington's Hypotheses, GSK Collaboration Catalysts To Move The Needle_seekingalpha.com
2023: Wave Life Sciences: What To Make Of The Discounted Offering_ seekingalpha.com
2024: Goodbye Wave: Takeda axes Huntington’s pact, freeing partner to pursue fresh interest
2024: Wave Clinical Trial Shows First Successful RNA Editing in Humans
2024: Wave Life Sciences Announces First-Ever Therapeutic RNA
2024: Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst
2024: Wave Life Sciences: Spiking On Strong DMD Data, But Not Fully De-Risked Yet
2024: Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche
2024: Wave surfs DMD success to regulators' doors, sending stock up
2025: Wave Life Sciences Is A Buy On Pipeline Prospects
2025: Wave Life Sciences: Speculative, But Promising
2025: Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months
2026: Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update